Athanasios Tsiatis
Director Técnico/Científico/I+D en ALX ONCOLOGY HOLDINGS INC. .
Perfil
Athanasios Tsiatis is currently the Senior Vice President-Clinical Development at ALX Oncology Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Plexxikon, Inc. from 2018 to 2021.
He completed his undergraduate degree at New York University and obtained his doctorate from Vanderbilt University School of Medicine.
Cargos activos de Athanasios Tsiatis
Empresas | Cargo | Inicio |
---|---|---|
ALX ONCOLOGY HOLDINGS INC. | Director Técnico/Científico/I+D | 01/11/2021 |
Antiguos cargos conocidos de Athanasios Tsiatis.
Empresas | Cargo | Fin |
---|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Director Técnico/Científico/I+D | 01/11/2021 |
Formación de Athanasios Tsiatis.
New York University | Undergraduate Degree |
Vanderbilt University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALX ONCOLOGY HOLDINGS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Athanasios Tsiatis